CeriBell Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 10, 2025

 

 

CeriBell, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware			333-281784	47-1785452
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
360 N. Pastoria Avenue
Sunnyvale, California				94085
(Address of Principal Executive Offices)				(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 800 436-0826

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.001 par value per share		CBLL		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

---

Item 5.02	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 10, 2025, the Board of Directors of CeriBell, Inc. (the “Company”), as part of its annual compensation review and award process, approved the following compensation adjustments for Xingjuan (Jane) Chao, Ph.D., the Company’s President and Chief Executive Officer, Scott Blumberg, the Company’s Chief Financial Officer, and Raymond Woo, Ph.D., the Company’s Chief Technology Officer, effective April 1, 2025: (1) Dr. Chao’s annual base salary was increased to $685,000 and her target annual incentive was increased to 95% of her base salary; (2) Mr. Blumberg’s annual base salary was increased to $460,000 and his target annual incentive was increased to 50% of his base salary; and (3) Dr. Woo’s annual base salary was increased to $444,000 and his target annual incentive was increased to 50% of his base salary.

 

 

Item 9.01	Financial Statements and Exhibits.
Exhibit No.		Description
104		Cover Page Interactive Data File, formatted in Inline XBRL.

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			CERIBELL, INC.
Date:	March 14, 2025	By:	/s/ Scott Blumberg
			Scott Blumberg Chief Financial Officer

 

---